Zura Bio Ltd ZURA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-16
Zura Bio Ltd statistics & valuation
Market cap$333.9M
P / B3.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -60.2% | -29.2% | -59.9% | -489.1% |
| Return on equity | -67.6% | -35.3% | -99.2% | 80.3% |
| Current ratio | 9.05 | 9.16 | 4.97 | 0.12 |
Source: SEC EDGAR filings · CIK 0001855644 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.